Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 74.08M | 72.51M | 67.38M | 66.79M | 49.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.08M | 72.51M | 67.38M | 66.79M | 49.30M |
| Cost of Revenue | 57.26M | 57.29M | 53.27M | 55.12M | 38.64M |
| Gross Profit | 16.82M | 15.22M | 14.12M | 11.67M | 10.65M |
| SG&A Expenses | 14.49M | 13.17M | 14.54M | 13.99M | 9.73M |
| Depreciation & Amortization | 5.51M | 6.63M | 1.49M | 2.60M | 364.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 77.26M | 77.09M | 69.29M | 70.35M | 48.74M |
| Operating Income | -3.18M | -4.58M | -1.91M | -3.57M | 557.00K |
| Income Before Tax | -7.62M | -10.52M | 2.40M | -5.39M | -9.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.62M | -10.52M | 2.40M | -5.39M | -9.66M |
| Earnings from Discontinued Operations | -- | -- | -248.00K | -3.45M | 67.07M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.62M | -10.52M | 2.15M | -8.83M | 57.42M |
| EBIT | -3.18M | -4.58M | -1.91M | -3.57M | 557.00K |
| EBITDA | 4.14M | 3.93M | 1.16M | -558.00K | 2.00M |
| EPS Basic | -0.09 | -0.12 | 0.03 | -0.10 | 0.70 |
| Normalized Basic EPS | -0.02 | -0.03 | 0.00 | -0.01 | 0.01 |
| EPS Diluted | -0.09 | -0.12 | 0.03 | -0.10 | 0.69 |
| Normalized Diluted EPS | -0.02 | -0.03 | 0.00 | -0.01 | 0.01 |
| Average Basic Shares Outstanding | 88.27M | 86.21M | 85.32M | 84.70M | 82.45M |
| Average Diluted Shares Outstanding | 88.27M | 86.21M | 90.17M | 84.70M | 82.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |